Publikationen

2019

Subtherapeutic Anticoagulation Control under Treatment with Vitamin K-Antagonists—Data from a Specialized Coagulation Service.
Prochaska JH, Hausner C, Nagler M, Göbel S, Eggebrecht L, Panova-Noeva M, Arnold N, Lauterbach M, Bickel C, Michal M, Hardt R, Espinola-Klein C, Lackner KJ, Münzel T, Wild PS. Thromb Haemost. 2019;119(8):1347-1357. doi: 10.1055/s-0039-1692175.

 

Relevance of Polypharmacy for Clinical Outcome in Patients Receiving Vitamin K Antagonists.
Eggebrecht L, Nagler M, Göbel S, Lamparter H, Keller K, Wagner B, Panova-Noeva M, Ten Cate V, Bickel C, Lauterbach M, Espinola-Klein C, Hardt R, Münzel T, Prochaska JH, Wild PS. J Am Geriatr Soc. 2019;67(3):463-470. doi: 10.1111/jgs.15712.


2018

Management of Oral Anti-Coagulation in Patients with Heart Failure—Insights from the ThrombEVAL Study.
Göbel S, Prochaska JH, Eggebrecht L, Schmitz R, Jünger C, Lamparter H, Nagler M, Keller K, Coldewey M, Tröbs SO, Diestelmeier S, Schwuchow-Thonke S, Bickel C, Lauterbach M, Lackner KJ, Cate HT, Münzel T, Hardt R, Wild PS. Thromb Haemost. 2018;118:1930-1939. doi: 10.1055/s-0038-1673380.

 

Sustained atrial fibrillation increases the risk of anticoagulation-related bleeding in heart failure.
Prochaska JH, Göbel S, Nagler M, Knöpfler T, Eggebrecht L, Lamparter H, Panova-Noeva M, Keller K, Coldewey M, Bickel C, Lauterbach M, Hardt R, Espinola-Klein C, Ten Cate H, Rostock T, Münzel T, Wild PS. Clin Res Cardiol. 2018;107:1170-1179. doi: 10.1007/s00392-018-1293-4.

 

[Physicians' Opinion on Health Care in Oral Anticoagulation].
Eggebrecht L, Prochaska JH, Schleuter L, Nagler M, Hardt R, Schinzel H, Münzel T, Wild PS. Dtsch Med Wochenschr. 2018;143:e76-e84. doi: 10.1055/s-0043-123041.


2017

e-Health-based management of patients receiving oral anticoagulation therapy: results from the observational thrombEVAL study.
Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Lamparter H, Schulz A, Schinzel H, Bickel C, Lauterbach M, Michal M, Hardt R, Binder H, Espinola-Klein C, Lackner KJ, Ten Cate H, Münzel T, Wild PS. J Thromb Haemost. 2017;15:1375-1385. doi: 10.1111/jth.13727.


2015

History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism.
Keller K, Prochaska JH, Coldewey M, Göbel S, Ullmann A, Jünger C, Lamparter H, Ariza L, Bickel C, Lauterbach M, Konstantinides S, Rostock T, Münzel T, Wild PS. Thromb Res. 2015;136:899-906. doi: 10.1016/j.thromres.2015.08.024.

 

Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program.
Michal M, Prochaska JH, Keller K, Göbel S, Coldewey M, Ullmann A, Schulz A, Lamparter H, Münzel T, Reiner I, Beutel ME, Wild PS. Int J Cardiol. 2015;187:614-619. doi: 10.1016/j.ijcard.2015.03.374.

 

Development of recommendations to continue anticoagulation with one of the two types of oral anticoagulants based on the identification of patients' preference.
Zolfaghari S, Harenberg J, Frölich L, Weiss C, Wehling M, Wild P, Prochaska J, Bayer-Westendorf J, Koscielny J, Lip GY. Semin Thromb Hemost. 2015;41:166-177. doi: 10.1055/s-0035-1546467.

 

Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service—results from the prospective, multi-center, observational cohort study thrombEVAL.
Prochaska JH, Göbel S, Keller K, Coldewey M, Ullmann A, Jünger C, Lamparter H, Al-Bayati Z, Baer C, Walter U, Bickel C, Ten Cate H, Münzel T, Wild PS. BMC Med. 2015;13:14. doi: 10.1186/s12916-015-0268-9.

 

Evaluation of oral anticoagulation therapy: rationale and design of the thrombEVAL study programme.
Prochaska JH, Coldewey M, Göbel S, Keller K, Hendelmeier M, Konstantinides S, Münzel T, Wild PS. Eur J Prev Cardiol. 2015;22:622-628. doi: 10.1177/2047487314527852.


2014

Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program.
Michal M, Prochaska JH, Ullmann A, Keller K, Göbel S, Coldewey M, Münzel T, Wiltink J, Beutel ME, Wild PS. J Thromb Haemost. 2014;12:2024-2033. doi: 10.1111/jth.12743.

Kontakt

Studienleitung:
Univ.-Prof. Dr.med. Philipp Wild, M.Sc.(federführend)
 philipp.wild@unimedizin-mainz.de


Studienzentrum:
Universitätsmedizin Mainz
Centrum für Thrombose und Hämostase Mainz
thrombEVAL - Studienzentrum
Gebäude 403, 1.OG
Langenbeckstrasse 1
55131 Mainz


Telefon:   06131 17-7439
Telefax:   06131 17-8460
E-Mail:     info@thrombeval.de